- Home
- Publications
- Publication Search
- Publication Details
Title
Eicosanoids in Cancer: New Roles in Immunoregulation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-18
DOI
10.3389/fphar.2020.595498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC
- (2020) Chiara Porta et al. CANCER RESEARCH
- PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model
- (2020) Tong Wang et al. ONCOGENE
- Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy
- (2020) Mc Millan Ching et al. Frontiers in Pharmacology
- Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors
- (2020) Eric A. Evangelista et al. Frontiers in Pharmacology
- Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
- (2019) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
- (2019) Deborah B Doroshow et al. CLINICAL CANCER RESEARCH
- Fatty acid transport protein 2 reprograms neutrophils in cancer
- (2019) Filippo Veglia et al. NATURE
- Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
- (2019) Nune Markosyan et al. JOURNAL OF CLINICAL INVESTIGATION
- EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
- (2019) Anna Hester et al. OncoTargets and Therapy
- Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma
- (2019) Hui Yang et al. PHARMACOLOGY
- A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell-potentiated colorectal carcinogenesis
- (2018) Guifang Yan et al. CANCER RESEARCH
- The cytochrome P450 slow metabolizers CYP2C9*2 and CYP2C9*3 directly regulate tumorigenesis via reduced epoxyeicosatrienoic acid production
- (2018) Lindsay N Sausville et al. CANCER RESEARCH
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- 5-Lipoxygenase: Its involvement in gastrointestinal malignancies
- (2018) Neha Merchant et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
- (2018) Mousumi Majumder et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of prostanoids in gastrointestinal cancer
- (2018) Dingzhi Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Leukotriene receptors as potential therapeutic targets
- (2018) Takehiko Yokomizo et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+ T lymphocytes in tumors that express MHC class II
- (2018) Howard Y. Li et al. OncoImmunology
- Regulation of TIM-3 expression in a human T cell line by tumor-conditioned media and cyclic AMP-dependent signaling
- (2018) Su Jin Yun et al. MOLECULAR IMMUNOLOGY
- What, Why, Where, and When: Bringing Timing to Immuno-Oncology
- (2018) Adrienne M. Rothschilds et al. TRENDS IN IMMUNOLOGY
- Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway
- (2017) Gillian Moore et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages
- (2017) Julia Ringleb et al. JOURNAL OF IMMUNOLOGY
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostaglandin synthases: Molecular characterization and involvement in prostaglandin biosynthesis
- (2017) Min-Ju Seo et al. PROGRESS IN LIPID RESEARCH
- The yin and yang of leukotriene B 4 mediated inflammation in cancer
- (2017) Venkatakrishna R. Jala et al. SEMINARS IN IMMUNOLOGY
- Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
- (2017) Sara Trabanelli et al. Nature Communications
- Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets
- (2017) Sabine Galland et al. Cell Reports
- Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
- (2017) Javier Rodríguez-Ubreva et al. Cell Reports
- Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression
- (2017) Venkatakrishna R. Jala et al. OncoImmunology
- Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer
- (2017) Saly Al-Taei et al. OncoImmunology
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+T Cell Migration into Tumors
- (2016) Zinal S. Chheda et al. JOURNAL OF IMMUNOLOGY
- Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung Cancer
- (2016) Joanna M. Poczobutt et al. JOURNAL OF IMMUNOLOGY
- Prostaglandin D2 is a novel repressor of IFNγ induced indoleamine-2,3-dioxygenase via the DP1 receptor and cAMP pathway
- (2016) Nesrine Kamal Bassal et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Peroxisome Proliferator-Activated Receptor γ and Lung Cancer Biology
- (2016) Jesse Roman JOURNAL OF INVESTIGATIVE MEDICINE
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment
- (2015) Joanna M. Poczobutt et al. JOURNAL OF IMMUNOLOGY
- Neutrophils support lung colonization of metastasis-initiating breast cancer cells
- (2015) Stefanie K. Wculek et al. NATURE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth
- (2015) Shuchismita R. Satpathy et al. Nature Communications
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration
- (2014) Z Wen et al. ONCOGENE
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Identification of GPR99 Protein as a Potential Third Cysteinyl Leukotriene Receptor with a Preference for Leukotriene E4Ligand
- (2013) Yoshihide Kanaoka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor
- (2013) K. Wejksza et al. JOURNAL OF IMMUNOLOGY
- Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells Is Required for Their Migration into Tumors To Elicit Effective Antitumor Immunity
- (2013) R. K. Sharma et al. JOURNAL OF IMMUNOLOGY
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer
- (2013) Pasi A. Jänne et al. Journal of Thoracic Oncology
- Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment
- (2013) Joanna M. Poczobutt et al. PLoS One
- Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells
- (2013) Anna Mari Lone et al. Frontiers in Immunology
- Lipids and eicosanoids in fibrosis
- (2012) Flavia V. Castelino CURRENT OPINION IN RHEUMATOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cyclooxygenases and lipoxygenases in cancer
- (2011) Claus Schneider et al. CANCER AND METASTASIS REVIEWS
- Prostaglandin catabolic enzymes as tumor suppressors
- (2011) Hsin-Hsiung Tai CANCER AND METASTASIS REVIEWS
- Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention
- (2011) Mary-Clare Cathcart et al. CANCER AND METASTASIS REVIEWS
- EET signaling in cancer
- (2011) Dipak Panigrahy et al. CANCER AND METASTASIS REVIEWS
- Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention
- (2011) A. Mohammed et al. Cancer Prevention Research
- Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers
- (2011) R. L. Keith et al. Cancer Prevention Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
- (2011) Dipak Panigrahy et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of inflammation in cancer by eicosanoids
- (2011) Emily R. Greene et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- 5-Lipoxygenase: Underappreciated Role of a Pro-Inflammatory Enzyme in Tumorigenesis
- (2011) Dieter Steinhilber et al. Frontiers in Pharmacology
- Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
- (2010) David G. DeNardo et al. CANCER AND METASTASIS REVIEWS
- Targeting the eicosanoid pathway in non-small-cell lung cancer
- (2009) Leora Horn et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development
- (2008) Juan J. Moreno BIOCHEMICAL PHARMACOLOGY
- NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non-Small Cell Lung Cancer
- (2008) D. Hughes et al. Cancer Prevention Research
- Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203
- (2008) Martin J. Edelman et al. JOURNAL OF CLINICAL ONCOLOGY
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started